These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12076521)

  • 21. Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1.
    Forkert PG; Baldwin RM; Millen B; Lash LH; Putt DA; Shultz MA; Collins KS
    Drug Metab Dispos; 2005 Oct; 33(10):1429-37. PubMed ID: 15987776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of theophylline by cDNA-expressed human cytochromes P-450.
    Ha HR; Chen J; Freiburghaus AU; Follath F
    Br J Clin Pharmacol; 1995 Mar; 39(3):321-6. PubMed ID: 7619675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.
    Madan A; Parkinson A; Faiman MD
    Drug Metab Dispos; 1995 Oct; 23(10):1153-62. PubMed ID: 8654205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes.
    Liu X; Wang Q; Chen M; Tao J; Wang J; Liu S; Hou J; Li D; Wang R
    J Ethnopharmacol; 2023 May; 308():116303. PubMed ID: 36841379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R; Bhateria M; Singh R; Bhatta RS
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.
    Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K
    Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats.
    Yun KU; Oh SJ; Oh JM; Kang KW; Myung CS; Song GY; Kim BH; Kim SK
    Arch Toxicol; 2010 Dec; 84(12):939-46. PubMed ID: 20130842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds.
    Nakajima M; Suzuki M; Yamaji R; Takashina H; Shimada N; Yamazaki H; Yokoi T
    Xenobiotica; 1999 Dec; 29(12):1191-202. PubMed ID: 10647906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cytochrome P450s: selectivity and measurement in vivo.
    Smith DA; Abel SM; Hyland R; Jones BC
    Xenobiotica; 1998 Dec; 28(12):1095-128. PubMed ID: 9890156
    [No Abstract]   [Full Text] [Related]  

  • 34. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
    Kobayashi K; Urashima K; Shimada N; Chiba K
    Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
    Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
    Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA; Green K; Birnbaum A; Remmel RP
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP [correction of CXP] and preservation of BSEP activities.
    Paolini M; Pozzetti L; Montagnani M; Potenza G; Sabatini L; Antelli A; Cantelli-Forti G; Roda A
    Hepatology; 2002 Aug; 36(2):305-14. PubMed ID: 12143038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.